LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 29.86 | 21.74 | 1083 | 1887 | 0.5739 | 0.8348 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 29.86 | 21.74 | 1435 | 1887 | 0.7605 | 0.9167 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 29.86 | 21.74 | 1791 | 1887 | 0.9491 | 0.9839 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 29.86 | 21.74 | 1857 | 1887 | 0.9841 | 0.9950 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 31.83 | 21.74 | 1240 | 2110 | 0.5877 | 0.8453 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 31.83 | 21.74 | 1509 | 2110 | 0.7152 | 0.9010 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 31.83 | 21.74 | 1908 | 2110 | 0.9043 | 0.9697 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 31.83 | 21.74 | 1994 | 2110 | 0.9450 | 0.9829 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 33.80 | 21.74 | 1361 | 2381 | 0.5715 | 0.8415 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 33.80 | 21.74 | 1602 | 2381 | 0.6727 | 0.8863 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 33.80 | 21.74 | 2144 | 2381 | 0.9003 | 0.9692 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 33.80 | 21.74 | 2190 | 2381 | 0.9196 | 0.9754 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 35.77 | 21.74 | 1474 | 2602 | 0.5663 | 0.8419 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 35.77 | 21.74 | 1690 | 2602 | 0.6493 | 0.8787 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 35.77 | 21.74 | 2283 | 2602 | 0.8771 | 0.9624 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 35.77 | 21.74 | 2343 | 2602 | 0.9002 | 0.9698 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 37.74 | 21.74 | 1677 | 2828 | 0.5929 | 0.8566 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 37.74 | 21.74 | 1818 | 2828 | 0.6428 | 0.8780 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 37.74 | 21.74 | 2407 | 2828 | 0.8510 | 0.9546 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 37.74 | 21.74 | 2482 | 2828 | 0.8775 | 0.9631 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 39.71 | 21.74 | 1759 | 3084 | 0.5703 | 0.8489 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 39.71 | 21.74 | 1916 | 3084 | 0.6212 | 0.8712 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 39.71 | 21.74 | 2517 | 3084 | 0.8161 | 0.9440 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 39.71 | 21.74 | 2617 | 3084 | 0.8485 | 0.9546 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 41.68 | 21.74 | 1871 | 3418 | 0.5473 | 0.8414 | MN20160310_N01 | D10 |